The Yankees announced a pair of roster moves, including the news that right-hander Cody Morris has been designated for assignment. The 40-man roster spot was required since right-hander Scott Effross was reinstated from the 60-day injured list, and then optioned to Triple-A.
Morris was acquired from the Guardians last December in exchange for Estevan Florial, and though Morris has been called up a couple of times this season, he has yet to make his official debut in a Yankees uniform. At the Triple-A level, Morris has a 4.25 ERA over 36 innings for Scranton/Wilkes-Barre, with a glaring 16% walk rate undermining a solid 25.8% strikeout rate.
The control problems have been apparent during Morris’ brief run in the big leagues, as he has a 13.% walk rate over 31 2/3 innings with Cleveland in 2022-23, albeit with a 3.41 ERA. The ERA breaks down as a 2.28 mark over 23 2/3 frames in 2022, but then a 6.75 ERA in eight innings last season, as Morris also missed time early in the season with a teres major strain. Morris also had an inflated walk rate during his time with the Guardians’ Triple-A affiliate in 2023, which likely made him an expendable arm for the Guards in the offseason.
Morris has worked primarily as a reliever over the last two seasons, though usually in multi-inning fashion given his past usage as a starting pitcher. This ability to eat innings out of the pen could make him an interesting candidate to be claimed off waivers, if a rival club is able to overlook his walks (or, thinks it can harness Morris’ control). Morris has never been outrighted before in his career, so if clears waivers here, he’ll have to report to the Yankees’ Triple-A affiliate in the event that the Yankees outright him off the 40-man roster rather than release him entirely.
The Cubs sent Effross to the Yankees at the trade deadline in 2022, and while his tenure in the Bronx had strong immediate results (a 2.13 ERA in 12 2/3 innings), Effross’ career was then put on hold by Tommy John surgery that October. He also underwent a back surgery this past February that delayed his return even further, but Effross has posted a 3.86 ERA and very strong secondary metrics in 9 1/3 innings over eight appearances during his rehab assignment. Effross looks like an intriguing secret weapon to join New York’s bullpen at some point in the second half, which will be a boost to a team that figures to be looking for relief help anyway at this year’s deadline.